This is best highlighted in the breast cancer field, where the proteins estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) have been well established as prospective treatment response biomarkers [7, 8]. The gene discussed is PGR; the disease is breast carcinoma.